Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Phillip A. Sharp currently holds 5,228 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Phillip A. Sharp has been a net seller of ALNY stock. They have purchased $0 and sold $25.8M worth of shares.
Phillip A. Sharp's most recent insider trade was on May 16, 2024, when they sold 5,228 shares at $0.00 per share.
Phillip A. Sharp serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 40 insider transactions totaling $25.8M over their tenure at the company.
Phillip A. Sharp holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Phillip A. Sharp has shown a selling trading pattern, with $0 in total purchases and $25.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Phillip A. Sharp was on Feb 9, 2022, when they sold $4.5M worth of ALNY shares. This transaction involved 30,000 shares at $150.00 per share.
Phillip A. Sharp currently owns 5,228 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Phillip A. Sharp's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Phillip A. Sharp has 40 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Phillip A. Sharp and 40,000+ other insiders.